Company Statement: Alexion to acquire Enobia Pharma
Mlex Summary: Alexion Pharmaceuticals has agreed to acquire Enobia Pharma for at least $610 million. In addition, $470 million may also be paid if various regulatory and sales milestones are achieved. The transaction, subject to regulatory approval, is expected...To view the full article, register now.
Already a subscriber? Click here to view full article